GENE ONLINE|News &
BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs
When a company enters the stock market, it allows the public to trade its shares. An Initial Public Offering (IPO) allows companies to offer new stocks to the investors and raise capital. Well-funded companies can do a direct listing, which allows them to sell existing shares and avoid the cost of a traditional IPO. However, it doesn’t let them raise more capital.
Over the last few years, Special Purpose Acquisition Company (SPAC) has become a more popular route to IPO.
It's free! Log in now to read
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
